How PMCF goes beyond simple compliance

Dr Paul Hercock
How PMCF goes beyond simple compliance - improving products and engaging customers

Given the time and resources needed to build an EU MDR-compliant regulatory system, it’s perhaps not surprising that there can be a temptation to adopt a ‘box ticking’ approach to certain aspects.

Video: How to build an EU MDR-compliant regulatory system for your medical devices

Our experience working with clients across the industry has shown that many companies seek to save money by using purely retrospective data for PMCF submissions, or attempt to justify non-performance of PMCF when they should, in reality, have a system in place.

In this article, we move away from the purely regulatory benefits of engaging fully with PMCF and consider the wider benefits of a well-designed PMCF system to your business, your products and your relationship with your clients.

PMCF benefits your business

Generating clinical data is expensive. Prospective studies, in particular, can pose significant resource challenges because, by definition, they run for months or years at a time, consuming resources as they do so. The allure of using retrospective data for PMCF is therefore easy to understand from a business planning perspective.

However, consider the requirements for PMCF in Annex XIV Part B of the EU MDR. The Annex calls for continuous and proactive data collection throughout the entire commercial lifetime of a device. In practical terms, achieving the latter criterion will be almost impossible with retrospective data; it would require repeated studies over time with one following immediately upon another. This, in turn, would require repeated investment, time, resource, approvals, documentation, statistical analysis and reporting. While using retrospective data may be attractive in the short term, in reality it may simply be compounding problems for the business’ future.

A better approach would be a single investment in a well-designed and future-proofed dedicated prospective PMCF study. Once set up, this single system could collect data on the safety and performance of a medical device or product family indefinitely, fulfilling the Annex XIV criteria in a single swoop. This would also prevent the need for constant updating of documents and repeated passage through study approval processes.

From a business perspective, it becomes easier to estimate resource requirements into the future with less duplication and wastage of time and money. Investing in a good-quality PMCF system for your devices can help safeguard both their regulatory approvals and your business over the coming years.

PMCF engages your customers

A further benefit provided by any well-designed PMCF system is the opportunity it provides for a further source of engagement with your customers. A change of emphasis from a “box ticking data collection exercise” to an opportunity to work collaboratively in promoting device safety is only one aspect of how PMCF can bring you and your customers closer together.

In particular, medical device PMCF registries call for close co-operation between customers (investigators) and manufacturer. Initial conversations about study participation, on-boarding processes, compliant remuneration frameworks, collating data and overcoming study-related challenges all provide important touch-points between manufacturer and customer, strengthening the sense of familiarity and co-operative working.

Furthermore, the act of selecting a clinical site may help them to feel valued and appreciated, cementing a positive relationship and, in turn, perception of your products and you as a company.

Customer relationships must be handled sensitively in relation to all forms of clinical study and PMCF is no exception. In particular, study participation must in no way act as an inducement to buy or use the product. And, as with all clinical studies, challenges will arise from time-to-time that may strain relationships.

However, the right approach from the outset can more than overcome any such challenges and companies that build a network of satisfied customers actively engaging in their PMCF activities stand to secure both their customer relations and their regulatory approval both now and well into the future.

Summary

For advice on designing and implementing PMCF studies that will benefit both your business and your customers, arrange a free consultation with a member of our team.

Uniquely, our advisors are all medical professionals who have decades of experience working as investigators in clinical studies. Through their ability to offer a direct perspective from the clinical side, our team can help ensure your PMCF studies are designed for maximum effectiveness, investigator appeal and data collection compliance. We also offer a risk-share model where our remuneration is tied directly to the success of your PMCF study.

This is Part 2 of our PMCF under the MDR article series. Subscribe to our Newsletter to ensure you don’t miss any of this comprehensive series.

Related articles

  1. Considering a medical device's intended purpose

    A medical device's intended purpose - what is the point?

    How do you define intended purpose, indication for use, intended clinical benefits, and claims?

    Dr Simon Cumiskey Dr Simon Cumiskey Lead Medical Writer
  2. Mantra Systems presents EnableChat, your AI-powered MDR & MDCG chatbot

    EnableChat - Your AI-powered MDR and MDCG chatbot

    Search the MDR and MDCG documents in seconds by asking EnableChat your questions.

    Dr Simon Cumiskey Dr Simon Cumiskey Lead Medical Writer
  3. Searching adverse event databases for vigilance data

    Staying vigilant - A guide to searching for adverse events data

    We discuss the pros and cons of existing adverse event databases for vigilance data searching.

    Dr Simon Cumiskey Dr Simon Cumiskey Lead Medical Writer
  4. A doctor reading an SSCP document with a patient

    What is Summary of Safety and Clinical Performance (SSCP)?

    We explain what the SSCP is, when you'll need it and what its objectives are.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  5. A pile of question marks

    Medical Device 'Significant Changes' – Navigating EU MDR Article 120(3) using MDCG 2020-3 rev. 1

    Understand what changes to your medical device are considered 'significant' under EU MDR (2017/745).

    Shen May Khoo Shen May Khoo Junior Regulatory Specialist
  6. A signpost giving unsure directions

    MDR or IVDR - A sibling rivalry?

    A guide to easily understanding whether your device is a medical device or an in vitro diagnostic medical device (IVD).

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  7. An EU and UK flag

    What the latest Brexit U-turn means for CE Marking of medical devices in Great Britain

    Will Great Britain continue to allow the use of the CE mark for medical devices beyond the 2024 deadline?

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  8. A woman writing her own medical device regulation documentation

    Gain confidence, reassurance and control over your EU MDR strategy

    Find out how to build your own technical files within a guided framework while minimising financial outlays.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  9. Racing to achieve MDR compliance

    Still racing to achieve MDR compliance? A transition period update

    On January 6th 2023, the EU commission has adopted the proposal to extend the transition rules of the EU MDR.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  10. A 7-step guide to navigating regulatory requirements for medical device start-ups

    A medical device regulations guide for start-up companies

    We present a 7-step guide to navigating regulatory requirements on a budget.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  11. An update on UKCA Marking of Medical Devices

    UKCA Marking of Medical Devices – An update on the status quo

    We review recently updated requirements for UKCA marking and what it means for your regulatory strategy.

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  12. How to choose a CER writer for your MDR Clinical Evaluation

    Choosing a CER writer for your MDR Clinical Evaluations

    We've compiled a list of considerations that will help you make the right choice when choosing a CER writer.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  13. Achieving MDR Compliance for Class I medical devices

    How to achieve MDR Compliance for Class I medical devices

    We outline a strategy for the regulatory compliance of Class I medical devices.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  14. Literature Search, SOTA Review and Clinical Evaluation

    Literature Search, SOTA Review process and Clinical Evaluation

    We help to demystify the process of systematic search & review of literature for Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  15. Literature Search Protocols & SOTA Reviews for medical devices and what to know before you start

    Literature searches and reviews for medical devices - what to know before you start

    We explain what you should know before beginning a literature search & review for your medical device.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  16. Five useful resources when writing a medical device CER

    Five useful resources when writing a medical device CER

    We outline five of the most useful and trustworthy Clinical Evaluation Report writing resources.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  17. Avoid pitfalls when writing a Clinical Evaluation Report

    Five common pitfalls when writing a Clinical Evaluation Report

    We illustrate five pitfalls when writing CERs and give you some tips to overcome them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  18. How to make a medical device equivalence claim under the MDR

    Five tips for making a medical device equivalence claim under the MDR

    We'll show you what to keep in mind with regards to equivalance and Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  19. Keeping medical devices in market and maintaining CE-marks - a guide to effective data collection

    Keeping medical devices in market and maintaining CE-marks

    The 4 golden rules to drive regulatory compliance with PMCF and vigilance data collection.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  20. PMCF systems for medical devices

    Why you'll almost certainly need a PMCF system for your medical devices

    We tell you what to be aware of under the EU MDR regarding PMCF and your medical devices.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  21. Ensure medical device regulatory compliance of your devices through Brexit

    The impact of Brexit on medical device regulatory compliance

    How to ensure regulatory alignment of your devices in the territories affected by Brexit.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  22. Use medical device regulatory consulting services to supercharge your MDR transition

    Is outside consulting support the answer to your MDR transition?

    Getting ready for the MDR is a demanding process. Outsourcing might be your solution.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  23. Increasing data entry compliance in PMCF studies

    Increasing data entry compliance in PMCF studies

    5 methods every medical device manufacturer should know to improve their Post-Market Clinical Follow-up studies.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  24. Why medical doctors can drive MDR compliance

    Why medical doctors can drive MDR compliance

    Working with the MDR requires knowing how to work with clinical evidence. Medical doctors are perfectly positioned to meet this requirement.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  25. Software as a Medical Device

    Software as a Medical Device

    Unless you have spent time working with medical device legislation in the past, the idea that software could be a medical device may be rather unexpected.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  26. clinical investigator for pmcf eu mdr compliance

    Ensuring that clinical investigations work in practice

    How can medical device manufacturers ensure valid clinical investigations when access to medical expertise remains limited?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  27. Coronavirus and medical device regulations

    Relaxing medical device regulatory requirements during a healthcare crisis

    During the coronavirus pandemic, how far should we go when relaxing medical device regulatory requirements?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  28. The new MDR compliance challenge

    The new MDR compliance challenge

    Across the industry, medical device companies are facing challenges in meeting the demands of the new Medical Device Regulations (MDR) 2017/745 framework.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  29. Sources of Real World Evidence for MDR compliance

    Sources of Real World Evidence for MDR compliance

    At Mantra Systems our objective is to make sure that our clients choose the method of real world data harvesting that is right for them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer

More articles

Do you need help with your regulatory strategy?

Talk to us